Beranda › Sklerosis Multipel › Florida
Uji klinis Sklerosis Multipel di Florida
14 studi untuk Sklerosis Multipel mencari peserta di lokasi di Florida.
Kota di Florida
Teks studi resmi (Bahasa Inggris)
A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity
- Aqualane Clinical Research, Naples
- USF Health, Tampa
Menerima pesertaFase 2
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06782490A Study of Ocrelizumab Administered Subcutaneously in Participants With Multiple Sclerosis Who Switch From an Approved Anti-CD20 Therapy
- Neurology Associates, PA, Maitland
Menerima pesertaFase 4
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07609719A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
- TG Therapeutics Investigational Trial Site, Altamonte Springs
- TG Therapeutics Investigational Trial Site, Boca Raton
- TG Therapeutics Investigational Trial Site, Clearwater
- dan 7 lainnya
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT06433752Clinical Applications of Advanced Ophthalmic Imaging
- Bascom Palmer Eye Institute, Miami
Menerima pesertaSukarelawan sehat diterima
Usia 18 hingga 99 · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT03135327Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis
- Neurology of Central Florida- Site Number : 8400147, Altamonte Springs
- Aqualane Clinical Research- Site Number : 8400026, Naples
- Neurology Associates of Ormond Beach- Site Number : 8400086, Ormond Beach
- dan 1 lainnya
Menerima pesertaFase 3
Usia 18 hingga 60 · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT07325292RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- University of South Florida, Department of Psychiatry and Behavioral Neuroscience, Tampa
Menerima pesertaFase 2
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT07002034Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis
- University of South Florida, Tampa
Menerima pesertaFase 3
Usia 10 hingga 17 · Semua jenis kelamin · Diperbarui 10 Sep 2026 · NCT06408259A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
- Neurology of Central FL Res Ctr, Altamonte Springs
- UF Health Cancer Center, Gainesville
- Homestead Assoc In Research Inc, Homestead
- dan 8 lainnya
Menerima pesertaFase 3
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 29 Jul 2026 · NCT07225504Neurologic Stem Cell Treatment Study
- MD Stem Cells, Coral Springs
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 26 Jun 2026 · NCT02795052Dry Needling in Multiple Sclerosis
- University of South Florida, Tampa
Menerima peserta
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 29 Mei 2026 · NCT07615725Wearable Focal Vibration Therapy on Upper Extremity Function of People With Multiple Sclerosis: A Pilot Study
- Norman Fixel Institute for Neurological Diseases, Gainesville
- University of Florida, Gainesville
Menerima peserta
Usia 18 hingga 100 · Semua jenis kelamin · Diperbarui 6 Mar 2026 · NCT07376772Effects of Torso Weighting on Muscle Activation During Balance Tests in Individuals With and Without Multiple Sclerosis
- University of St. Augustine for Health Sciences, Saint Augustine
Menerima pesertaSukarelawan sehat diterima
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 20 Mei 2025 · NCT06981013Safety, PK and Biodistribution of 18F-OP-801 in Patients With ALS, AD, MS, PD and Healthy Volunteers
- Mayo Clinic Jacksonville, Jacksonville
Menerima pesertaFase 1/2Sukarelawan sehat diterima
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 2 Mei 2025 · NCT05395624Longitudinal Cognitive Assessment by BoCA
- Andrey Vyshedskiy, Miami
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 50 ke atas · Semua jenis kelamin · Diperbarui 1 Agu 2024 · NCT04114994Dari ClinicalTrials.gov, data diambil 2 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.